In vitro safety "clinical trial" of the cardiac liability of drug polytherapy

• Hoofdauteurs: Bérénice Charrez (Auteur), Verena Charwat (Auteur), Brian Siemons (Auteur), Henrik Finsberg (Auteur), Evan W. Miller (Auteur), Andrew G. Edwards (Auteur), Kevin E. Healy (Auteur)
• Formaat: Boek
• Gepubliceerd in: Wiley, 2021-05-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Abstract Only a handful of US Food and Drug Administration (FDA) Emergency Use Authorizations exist for drug and biologic therapeutics that treat severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) infection. Potential therapeutics include repurposed drugs, some with cardiac liabilities. We...